XML 12 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Interim Statements of Comprehensive Loss - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Expenses    
General and administrative $ 2,244,000 $ 3,298,000
Demonstration Plant operations 855,000 1,466,000
Management and directors' fees 477,000 490,000
Share-based compensation 1,420,000 2,681,000
Separation benefits 100,000  
Other 6,000  
Foreign exchange loss (gain) 2,000 (124,000)
Loss from operations 5,104,000 7,811,000
Interest and other income 250,000 152,000
Fair value gain on Investment in Aqualung 2,990,000  
Fair value gain on financial asset - FID 741,000 0
Investment loss from joint ventures (984,000)  
Interest expense (10,000) (14,000)
Net loss before income taxes (2,117,000) (7,673,000)
Deferred income tax benefit (567,000)  
Net loss (1,550,000) (7,673,000)
Item that may be reclassified subsequently to income or loss:    
Currency translation differences of foreign operations 20,000 (10,000)
Total comprehensive loss $ (1,530,000) $ (7,683,000)
Weighted average number of common shares outstanding - basic 192,568,062 178,223,074
Weighted average number of common shares outstanding - diluted 192,568,062 178,223,074
Basic loss per share (in USD per share) $ (0.01) $ (0.04)
Diluted loss per share (in USD per share) $ (0.01) $ (0.04)